Imricor is the global leader in the development and manufacture of MRI compatible devices for performing cardiac ablations. A cardiac ablation is a procedure conducted by an electrophysiologist where a catheter is guided into the heart with the purpose of burning/ablating the tissue responsible for causing the arrythmia (irregular heartbeat).

The cardiac ablation market, which is over US$8bn per year, currently uses X-Ray guidance to identify the location in the heart that requires treatment. X-Ray as an imaging tool has limitations as it does not show the soft tissue of the heart and exposes the patients and physicians to repeated radiation.

Imricor has the only cardiac ablation devices in the world that have been proven to be safe and effective inside the magnetic field generated by an MRI and, after 18 years of research and development, is now commercialising globally with approvals in Europe, the Middle East and soon to be in both Australia (2024) and the US (2025). The technology is protected by over 70 global patents.

KEY PEOPLE

  • Steve Wedan | Founder and CEO

     Steve founded Imricor in 2006 and is the company’s President and CEO.

    Steve has over 30 years of experience in the medical device industry including design engineering of MRI and ultrasound systems and GE Healthcare.

     

    Mr Wedan is a member of various international standards committees in the fields of MRI safety and the compatibility of implanted and interventional products in MRI

    Mr Wedan holds a Bachelor of Science in Electrical Engineering from Michigan Technological University (summa cum laude), and a Master of Science in Electrical Engineering from Marquette University.

    read more

  • Jonothon Gut | CFO

    Mr Gut joined Imricor in 2020 and has served as the Company’s Chief Financial Officer since July 2022. As CFO, he is responsible for overseeing financial operations, directing strategic financial planning, managing capital resources, and overseeing the company’s information technology and human resources functions.

    Mr Gut has over 15 years of accounting and finance experience, the last 12 of them in the medical device industry, having previously worked for both private and publicly owned companies, including Galil Medical and Boston Scientific.

    Mr Gut holds a Bachelor of Accounting from the University of Minnesota-Duluth and a Master of Accountancy from the University of Minnesota-Twin Cities. He is a licensed Certified Public Accountant.

    read more

  • Nick Corkill | Vice President Corporate Strategy

    Mr Corkill joined Imricor in 2024 and is responsible for Corporate Strategy, Investor Communications and Capital Markets.

    Prior to joining Imricor, Mr Corkill spent 15 years in Asset Management initially as an Equity Analyst at Perpetual Investments followed by 7 years as a Portfolio Manager at BlackRock Inc. and more recently as Portfolio Manager of the Lennox Capital Future Leaders Fund.

    Mr Corkill holds a Bachelor of Commerce from Lincoln University and a Bachelor of Arts from University of Canterbury.

    read more

RELATED STOCKHEAD STORIES